This site is intended for our US customers. If you wish to visit our International site, please choose your appropriate region using the selector in the top right of this page.

Icon / Search Created with Sketch.
Icon / Close Created with Sketch.

MosaiQ™ Future Developments

MosaiQ Microarrays

MosaiQ microarrays have been developed to meet the changing needs of donor testing laboratories.

 

Quotient is an active member of several global groups and collaborations that help shape the future diagnostic landscape. Our company constantly monitors the market, working with external groups so we can be proactive in incorporating new assays on MosaiQ to meet future demands.

Moving forward:

We are currently in the process of developing molecular disease screening capabilities for MosaiQ, including NAT (nucleic acid testing). This will supplement the blood grouping and serological disease screening capabilities of the MosaiQ system.